Verhoeven, M. M. A., Tekstra, J., Welsing, P. M. J., Pethö-Schramm, A., Borm, M. E. A., Bruyn, G. A. W., . . . Jacobs, J. W. G. (2020). Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate. Rheumatology (Oxford).
Citação norma ChicagoVerhoeven, Maxime M A., et al. "Effectiveness and Safety Over 3 Years After the 2-year U-Act-Early Trial of the Strategies Initiating Tocilizumab And/or Methotrexate." Rheumatology (Oxford) 2020.
Citação norma MLAVerhoeven, Maxime M A., et al. "Effectiveness and Safety Over 3 Years After the 2-year U-Act-Early Trial of the Strategies Initiating Tocilizumab And/or Methotrexate." Rheumatology (Oxford) 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.